LakePharma Announces Dedicated Vector Center to Support Gene and Cell TherapyAdded On: 2019-02-26
LakePharma Announces its GMP Biorepository Facility near Boston is Now Operational, Plans Additional HiringAdded On: 2019-01-15
LakePharma announces its cGMP microBiomanufacturing Center is now operationalAdded On: 2018-12-18
Added On: 2016-05-09
LakePharma announced today that it has entered into a strategic partnering alliance with Trianni, Inc., a private biotech company developing novel antibody discovery platforms. The agreement grants LakePharma the right to utilize the Trianni Mouse Platform for antibody discovery services.
The Trianni Mouse Platform enables the expression of antibodies with fully human variable domains, leveraging in-vivo selection to increase antibody diversity and quality. After validating the platform, LakePharma is pleased to now offer the Trianni Platform as part of its antibody discovery service offerings.
View the full press release here.